| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/04/2006 | US7024217 Access parameter adaptation and packet data resource management using detailed mobile status information |
| 04/04/2006 | US7022856 Carboline derivatives |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022732 6-substituted 2,3-dihydro-1,4-benzodioxine, 2-position substituted with carboxy, or (C1 C6)alkoxycarbonyl; diabetes, obesity; 6-[2-(R)-[2-(S)-hydroxy-3-(4-hydroxy-3-methanesulfonamido-phenoxy)propylamino]propyl]-2,3-dihydro-1,4-benzodioxine-2-(R)-carboxylic acid; B3 andrenergic receptor agonist |
| 04/04/2006 | US7022717 Chemokine receptor binding heterocyclic compounds |
| 04/04/2006 | US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/04/2006 | US7022710 A1 adenosine receptor antagonists |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022706 Central nervous system disorders |
| 04/04/2006 | US7022696 Treatment of airway disorders |
| 04/04/2006 | US7022690 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 04/04/2006 | US7022689 5-amidino-n-(2-aminophenethyl)-n-hydroxy-benzenesulffonamide derivative, medical composition containing the same, pharmaceutical use thereof and intermediate therefor |
| 04/04/2006 | US7022687 for treatment of allergies and airway disorders such as allergic rhinitis |
| 04/04/2006 | US7022686 A1 adenosine receptro antagonists |
| 04/04/2006 | US7022678 Pregabalin lactose conjugates |
| 04/04/2006 | US7022671 Surfactant protein C esters |
| 04/04/2006 | US7022521 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
| 04/04/2006 | US7022506 Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 03/30/2006 | WO2006032364A1 Lozenges based on mucolytic drugs for inflammatory diseases of the mouth and pharynx |
| 03/30/2006 | WO2006014864A3 Methods and compositions for reducing c-reactive protein |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069265 Reacting cysteine (or a salt or an ester) and an aryl carboxylic acid to form a thiazoline ring; stereospecifically alkylating the thiazoline ring, and hydrolyzing the thiazoline ring to obtain a 2-alkylcysteine; chelation |
| 03/30/2006 | US20060069148 Prostaglandins for prostaglandin mediated diseases such as antihistamines |
| 03/30/2006 | US20060069131 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 03/30/2006 | US20060069130 Novel crystals |
| 03/30/2006 | US20060069129 Chemokine receptor binding heterocyclic compounds |
| 03/30/2006 | US20060069126 Pharmaceutically active isoindoline derivatives |
| 03/30/2006 | US20060069120 Novel piperidine derivaties as modulators of chemokine receptor ccr5 |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |
| 03/30/2006 | US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 03/30/2006 | US20060068480 Polypeptides and polypeptide analogues |
| 03/30/2006 | DE102004046236A1 Arzneimittelzubereitung The pharmaceutical preparation |
| 03/30/2006 | DE102004046235A1 Arzneimittelzubereitung The pharmaceutical preparation |
| 03/30/2006 | DE102004039011A1 Extract, useful to prepare a medicament to treat e.g. gastrointestinal pain, cramps of urogenital tracts, asthma, cough and headache, comprises Petasites hybridus extract, that is free of pyrrolizidine alkaloid and furanoeremophilane |
| 03/30/2006 | CA2580881A1 Use of microproteins as tryptase inhibitors |
| 03/30/2006 | CA2579406A1 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as protein kinase inhibitors |
| 03/30/2006 | CA2577772A1 Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases |
| 03/29/2006 | EP1640369A1 Thiazolimine compound and oxazolimine compound |
| 03/29/2006 | EP1640003A2 Compositions comprising a Cyclooxygenase-2 Inhibitor and a Leukotriene B4 receptor antagonist |
| 03/29/2006 | EP1639998A1 Plant mucilage based lozenges against inflammatory diseases of the buccal and pharyngeal cavity |
| 03/29/2006 | EP1638940A2 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor |
| 03/29/2006 | EP1638925A1 Protease inhibitors |
| 03/29/2006 | EP1638603A1 Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies |
| 03/29/2006 | EP1638567A1 Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases |
| 03/29/2006 | EP1638555A1 Substituted 5-membered ring compounds and their use |
| 03/29/2006 | EP1638552A2 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 03/29/2006 | EP1638542A1 Use of n-alkanols as activators of the cftr channel |
| 03/29/2006 | EP1638525A2 Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 03/29/2006 | EP1330453B1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/29/2006 | EP1256587B1 Novel pseudoerythromycin derivatives |
| 03/29/2006 | EP1226279B1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 03/29/2006 | EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor |
| 03/29/2006 | CN1753678A Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients |
| 03/29/2006 | CN1753674A Use of tenatoprazole for the treatment of gastroesophageal reflux |
| 03/29/2006 | CN1752106A Method of manufacturing human antibody possessing bioreceptor synergist, antagonist and/or inverse synergist |
| 03/29/2006 | CN1752099A SARS-S antigen polypeptide capable of inducing producing specificity immune response |
| 03/29/2006 | CN1751733A Soft capsule of traditional Chinese medicine Angong Niuhuang and its prepn. method |
| 03/29/2006 | CN1751730A Traditional Chinese medicine for treating anaphylactic rhinitis and its prepn. method |
| 03/29/2006 | CN1751727A Method for preparing throat-clearing aerosol |
| 03/29/2006 | CN1751721A Traditional Chinese medicine soft capsule for ventilating regulating lung, and its prepn. method |
| 03/29/2006 | CN1751714A Novel administration route for compound injection contg. dandelion and its prepn. method |
| 03/29/2006 | CN1751713A Recipe of |
| 03/29/2006 | CN1751700A Novel administration route of isatis root injection for relieving internal heat, and prepn. technique and application thereof |
| 03/29/2006 | CN1751686A Novel form of asimidazole for treating chronic rhinitis |
| 03/29/2006 | CN1751685A Novel forms of Asimidazole for treating anaphylactic rhinitis |
| 03/29/2006 | CN1751684A Novel form of Asimidazole for treating nasal polyls or its disease |
| 03/29/2006 | CN1751682A Novel form of Asimidazole for treating adenoids hypertrophia |
| 03/29/2006 | CN1751681A Novel form of Asimidazole for treating chronic nasosinusitis |
| 03/29/2006 | CN1247780C Mammalian sytokine-like polypeptide-10 |
| 03/29/2006 | CN1247593C Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 03/29/2006 | CN1247591C Indole derivative and its medicine application |
| 03/29/2006 | CN1247583C Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound |
| 03/29/2006 | CN1247577C Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247575C Sulfamino ether substituted imidazoquinolines |
| 03/29/2006 | CN1247570C Novel pyridyl cyanoguandine compounds |
| 03/29/2006 | CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247542C Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 03/29/2006 | CN1247523C Substituted 1 and 2 naphthol mannich bases |
| 03/29/2006 | CN1247261C Combined bacterin for treating allergic disease and preparation method |
| 03/29/2006 | CN1247259C Recombinant human interferon alpha spray |
| 03/29/2006 | CN1247240C Herbal medicine compositions for treatment allergic rhinitis and use thereof |
| 03/29/2006 | CN1247221C Compound preparation of ypercritical carbon dioxide extraction of magnolia bark and cnidium fruit |
| 03/29/2006 | CN1247218C Medicinal composition for treating nasosinusitis and preparation method of its adhesive plaster |
| 03/29/2006 | CN1247189C Chinese medicine compound formula preparation for treating asthma disease |
| 03/29/2006 | CN1247127C Cigarette without nicotine |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019030 Immunotherapeutic agents |
| 03/28/2006 | US7019022 such as ((1R)-6-fluoro-8-(methylsulfonyl)-9-{(1S)-1-[4-(trifluoromethyl)phenyl]ethyl}-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetic acid for treatment of prostaglandin D2 mediated diseases such as rhinitis, asthma and nasal congestion |
| 03/28/2006 | US7019013 Sulfamidothienopyrimidines |
| 03/28/2006 | US7019007 CCR-3 receptor antagonists (I) |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7019001 Substituted benzothiazole amide derivatives |
| 03/28/2006 | US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |
| 03/28/2006 | US7018825 DNase liquid solutions |
| 03/28/2006 | US7017573 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 03/28/2006 | CA2415750C Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |